ASML vs. Applied Materials: Why One Is the Smarter Buy Right Now

ASML posted Q1 FY2026 revenue of $10.34B with a 53.0% gross margin (high end of guidance) and raised full-year guidance to €36–€40B, underpinned by EUV pricing power and a $45.06B year-end backlog. Applied Materials reported Q2 FY2026 revenue of $7.91B (+11.4% YoY) with non-GAAP EPS of $2.86 beating consensus by 7.52%, but free cash flow fell 80.21% YoY, suggesting working-capital strain. Net takeaway: AI capex momentum supports both names, but ASML’s moat and buyback program are viewed as more defensively durable than AMAT’s cyclical recovery.

Analysis

ASML is the cleaner structural winner because its revenue mix is migrating toward a recurring service stream while the installed base becomes more strategically indispensable as AI node transitions tighten. That makes the stock less sensitive to the next quarter’s capex wobble and more tied to the durability of advanced-node roadmaps; the key watch is not demand today, but whether order intake remains strong enough to support the 12-18 month High-NA ramp without a backlog air pocket.

AMAT is more exposed to a second-order problem: when AI budgets get reallocated toward HBM, packaging, or leading-edge litho, deposition/etch can still grow, but pricing and mix are less protected. Its upside is real in a cyclical recovery, yet that also means the next 1-3 months matter more — if foundry spending pauses, China mix rises further, or working capital stays stretched, the multiple can compress quickly even with decent revenue growth. INTC is the latent loser if EUV/High-NA timing slips, because any delay extends its process gap versus TSMC and deepens its reliance on outside capital discipline.

Consensus looks a bit too comfortable treating both names as AI beta. The market may be underpricing the dispersion between a monopoly supplier with buybacks and a high-beta recovery story with insider selling and weaker cash conversion. Falsifiers: ASML order/backlog miss, FY26 guide cut, or export restrictions worsening; AMAT FCF failing to inflect over the next two quarters, or DRAM/HBM demand normalizing faster than expected.

Key Decisions for Investors

• Long ASML / short AMAT as a 3-6 month relative-value pair: own the monopoly moat and recurring service mix versus the more valuation-sensitive cyclical recovery.
• Add to ASML on any post-earnings pullback only if backlog and FY26 guidance remain intact; use a stop on any material order slowdown or China-related guide cut.
• Fade AMAT strength with a tactical short-dated put spread into the next earnings window if the stock keeps rerating faster than FCF conversion improves.
• Watch TSM as the upstream beneficiary of ASML supply priority; if lithography lead times extend without order cancellations, TSM can outperform semi equipment beta over the next 6-12 months.
• Treat INTC as an event-driven watchlist name, not a core long: any delay in EUV/High-NA availability or node slip would be a relative negative versus TSM and ASML over 6-18 months.